Valeo Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.03M Sell
2,530
-1,698
-40% -$689K 0.03% 293
2025
Q1
$2.1M Sell
4,228
-34
-0.8% -$16.9K 0.06% 151
2024
Q4
$2.22M Sell
4,262
-86
-2% -$44.7K 0.06% 139
2024
Q3
$2.69M Buy
4,348
+198
+5% +$122K 0.08% 124
2024
Q2
$2.3M Buy
4,150
+111
+3% +$61.4K 0.07% 129
2024
Q1
$2.33M Buy
4,039
+255
+7% +$147K 0.08% 129
2023
Q4
$2.01M Buy
3,784
+385
+11% +$204K 0.08% 136
2023
Q3
$1.72M Buy
3,399
+214
+7% +$108K 0.08% 145
2023
Q2
$1.66M Sell
3,185
-515
-14% -$269K 0.08% 142
2023
Q1
$2.13M Buy
3,700
+1,012
+38% +$583K 0.1% 118
2022
Q4
$1.48M Buy
2,688
+343
+15% +$189K 0.08% 145
2022
Q3
$1.19M Buy
2,345
+578
+33% +$293K 0.08% 153
2022
Q2
$958K Sell
1,767
-1,049
-37% -$569K 0.06% 168
2022
Q1
$1.66M Buy
2,816
+767
+37% +$453K 0.08% 134
2021
Q4
$1.37M Sell
2,049
-3
-0.1% -$2K 0.07% 145
2021
Q3
$1.17M Buy
2,052
+685
+50% +$391K 0.07% 155
2021
Q2
$690K Buy
1,367
+50
+4% +$25.2K 0.04% 198
2021
Q1
$601K Buy
1,317
+207
+19% +$94.5K 0.03% 242
2020
Q4
$517K Buy
1,110
+34
+3% +$15.8K 0.03% 238
2020
Q3
$475K Sell
1,076
-573
-35% -$253K 0.04% 191
2020
Q2
$597K Buy
1,649
+130
+9% +$47.1K 0.05% 168
2020
Q1
$478K Sell
1,519
-244
-14% -$76.8K 0.05% 173
2019
Q4
$573K Buy
1,763
+200
+13% +$65K 0.06% 177
2019
Q3
$455K Buy
1,563
+8
+0.5% +$2.33K 0.05% 181
2019
Q2
$457K Sell
1,555
-356
-19% -$105K 0.05% 186
2019
Q1
$523K Buy
1,911
+38
+2% +$10.4K 0.06% 173
2018
Q4
$419K Sell
1,873
-19
-1% -$4.25K 0.06% 179
2018
Q3
$442K Buy
1,892
+25
+1% +$5.84K 0.06% 184
2018
Q2
$431K Buy
1,867
+158
+9% +$36.5K 0.06% 185
2018
Q1
$353K Sell
1,709
-500
-23% -$103K 0.06% 190
2017
Q4
$419K Buy
2,209
+2,176
+6,594% +$413K 0.07% 167
2017
Q3
$6K Buy
+33
New +$6K ﹤0.01% 838